These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus. Reveille JD; Arnett FC; Wilson RW; Bias WB; McLean RH Immunogenetics; 1985; 21(4):299-311. PubMed ID: 3873410 [TBL] [Abstract][Full Text] [Related]
3. Serologic studies in a family with heterozygous C2 deficiency. McCarty DJ; Tan EM; Zvaifler NJ; Koethe S; Duquesnoy RJ Am J Med; 1981 Dec; 71(6):945-8. PubMed ID: 6797295 [TBL] [Abstract][Full Text] [Related]
4. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Graham RR; Ortmann W; Rodine P; Espe K; Langefeld C; Lange E; Williams A; Beck S; Kyogoku C; Moser K; Gaffney P; Gregersen PK; Criswell LA; Harley JB; Behrens TW Eur J Hum Genet; 2007 Aug; 15(8):823-30. PubMed ID: 17406641 [TBL] [Abstract][Full Text] [Related]
5. Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies. Meyer O; Hauptmann G; Tappeiner G; Ochs HD; Mascart-Lemone F Clin Exp Immunol; 1985 Dec; 62(3):678-84. PubMed ID: 3878757 [TBL] [Abstract][Full Text] [Related]
6. Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: disease association with the extended haplotype [HLA-B8, SC01, DR17]. Truedsson L; Sturfelt G; Johansen P; Nived O; Thuresson B J Rheumatol; 1995 Oct; 22(10):1852-61. PubMed ID: 8991981 [TBL] [Abstract][Full Text] [Related]
7. Family studies of B lymphocyte alloantigens in systemic lupus erythematosus. Reinersten JL; Klippel JH; Johnson AH; Steinberg AD; Decker JL; Mann DL J Rheumatol; 1982; 9(2):253-62. PubMed ID: 6980280 [TBL] [Abstract][Full Text] [Related]
8. Association of HLA-DR7 with both antibody to SSA(Ro) and disease susceptibility in blacks with systemic lupus erythematosus. Wilson WA; Scopelitis E; Michalski JP J Rheumatol; 1984 Oct; 11(5):653-7. PubMed ID: 6334744 [TBL] [Abstract][Full Text] [Related]
9. Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Bell DA; Maddison PJ Arthritis Rheum; 1980 Nov; 23(11):1268-73. PubMed ID: 6969593 [TBL] [Abstract][Full Text] [Related]
10. [HLA markers and complotypes: risk factors in systemic lupus erythematosus?]. Gougerot A; Stoppa-Lyonnet D; Poirier JC; Schmid M; Busson M; Marcelli A Ann Dermatol Venereol; 1987; 114(3):329-34. PubMed ID: 3605963 [TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Hochberg MC; Boyd RE; Ahearn JM; Arnett FC; Bias WB; Provost TT; Stevens MB Medicine (Baltimore); 1985 Sep; 64(5):285-95. PubMed ID: 2412088 [TBL] [Abstract][Full Text] [Related]
12. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families. Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512 [TBL] [Abstract][Full Text] [Related]
13. Inherited deficiency of the second component of complement. Rheumatic disease associations. Glass D; Raum D; Gibson D; Stillman JS; Schur PH J Clin Invest; 1976 Oct; 58(4):853-61. PubMed ID: 965492 [TBL] [Abstract][Full Text] [Related]
15. Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE). Granados J; Vargas-Alarcón G; Drenkard C; Andrade F; Melín-Aldana H; Alcocer-Varela J; Alarcón-Segovia D Lupus; 1997; 6(1):57-62. PubMed ID: 9116720 [TBL] [Abstract][Full Text] [Related]
16. Familial systemic lupus erythematosus: the role of genetic and environmental factors. Eroglu GE; Kohler PF Ann Rheum Dis; 2002 Jan; 61(1):29-31. PubMed ID: 11779754 [TBL] [Abstract][Full Text] [Related]
17. Immunogenetics of systemic lupus erythematosus in Spanish patients: differential HLA markers. Gómez-Reino JJ; Martínez-Laso J; Vicario JL; Paz-Artal E; Aragón A; Martín-Villa JM; De Juan MD; Pérez-Aciego P; Arnaiz-Villena A Immunobiology; 1991 Aug; 182(5):465-71. PubMed ID: 1916886 [TBL] [Abstract][Full Text] [Related]
18. The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group. Hartung K; Ehrfeld H; Lakomek HJ; Coldewey R; Lang B; Krapf F; Müller R; Schendel D; Deicher H; Seelig HP Rheumatol Int; 1992; 11(6):243-9. PubMed ID: 1579805 [TBL] [Abstract][Full Text] [Related]
19. Diversity and pattern of inheritance of autoantibodies in families with multiple cases of systemic lupus erythematosus. Shoenfeld Y; Slor H; Shafrir S; Krause I; Granados J; Villarreal GM; Alarcón-Segovia D Ann Rheum Dis; 1992 May; 51(5):611-8. PubMed ID: 1616325 [TBL] [Abstract][Full Text] [Related]
20. No direct correlation between HLA-DPB1 and antibodies against recombinant Ro (SS-A)/La (SS-B) proteins in systemic lupus erythematosus. SLE Study Group. Yao Z; Hartung K; Ehrfeld H; Seelig HP; Deicher HG; Brünnler G; Keller E; Albert E Rheumatol Int; 1993; 13(4):155-8. PubMed ID: 8310208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]